Extended-release Injectable Buprenorphine Initiation in the Emergency Department
Introduction: Extended-release buprenorphine (XR-BUP) is a long-acting injectable medication used for the treatment of opioid use disorder (OUD). It is currently approved for use in patients who have been administered at least seven days of sublingual buprenorphine (SL-BUP). For patients with OUD wh...
Saved in:
| Main Authors: | Brittany Cesar, Jessica Moore, Raluca Isenberg, Jessica Heil, Rachel Rafeq, Rachel Haroz, Matthew Salzman, Alice V. Ely |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eScholarship Publishing, University of California
2025-07-01
|
| Series: | Western Journal of Emergency Medicine |
| Online Access: | https://escholarship.org/uc/item/4w26s0k3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Emergency Department Training on Buprenorphine Prescribing and Opioid Use Disorder-Associated ED Revisits: Retrospective Cohort Study
by: Anna Torchiano, et al.
Published: (2025-03-01) -
Advancing emergency department–initiated buprenorphine
by: Kristen Huntley, et al.
Published: (2021-06-01) -
Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy
by: Pouya Azar, et al.
Published: (2025-01-01) -
Emergency department‐initiated buprenorphine protocols: A national evaluation
by: Clara Z. Guo, et al.
Published: (2021-12-01) -
Buprenorphine/naloxone initiation in the emergency department: A series of vignettes
by: Margarita Popova, et al.
Published: (2024-12-01)